1. Home
  2. ACCL vs LONA Comparison

ACCL vs LONA Comparison

Compare ACCL & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acco Group Holdings Limited Ordinary Shares

ACCL

Acco Group Holdings Limited Ordinary Shares

SELL

Current Price

$2.40

Market Cap

36.3M

ML Signal

SELL

Logo LeonaBio Inc. Common Stock

LONA

LeonaBio Inc. Common Stock

HOLD

Current Price

$3.39

Market Cap

32.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACCL
LONA
Founded
2009
2011
Country
Hong Kong
United States
Employees
N/A
19
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.3M
32.7M
IPO Year
2024
2020

Fundamental Metrics

Financial Performance
Metric
ACCL
LONA
Price
$2.40
$3.39
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $16.67
AVG Volume (30 Days)
1.7K
★ 56.3K
Earning Date
11-27-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.13
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.23
$2.21
52 Week High
$4.98
$14.21

Technical Indicators

Market Signals
Indicator
ACCL
LONA
Relative Strength Index (RSI) 39.61 26.74
Support Level $1.33 $2.21
Resistance Level $2.89 $9.78
Average True Range (ATR) 0.06 0.44
MACD -0.02 -0.10
Stochastic Oscillator 21.98 3.27

Price Performance

Historical Comparison
ACCL
LONA

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

About LONA LeonaBio Inc. Common Stock

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Share on Social Networks: